Differences in Characteristics and Comorbidity of Cluster Headache According to the Presence of Migraine
Overview
Authors
Affiliations
Background And Purpose: Cluster headache (CH) can present with migrainous symptoms such as nausea, photophobia, and phonophobia. In addition, an overlap between CH and migraine has been reported. This study aimed to determine the differences in the characteristics of CH according to the presence of comorbid migraine.
Methods: This study was performed using data from a prospective multicenter registry study of CH involving 16 headache clinics. CH and migraine were diagnosed by headache specialists at each hospital based on third edition of the International Classification of Headache Disorders (ICHD-3). We interviewed patients with comorbid migraine to obtain detailed information about migraine. The characteristics and psychological comorbidities of CH were compared between patients with and without comorbid migraine.
Results: Thirty (15.6%) of 192 patients with CH had comorbid migraine, comprising 18 with migraine without aura, 1 with migraine with aura, 3 with chronic migraine, and 8 with probable migraine. Compared to patients with CH without migraine, patients with CH with comorbid migraine had a shorter duration of CH after the first episode [5.4±7.4 vs. 9.0±8.2 years (mean±standard deviation), =0.008], a lower frequency of episodic CH (50.0% vs. 73.5%, =0.010), and a higher frequency of chronic CH (13.3% vs. 3.7%, =0.033). Psychiatric comorbidities did not differ between patients with and without comorbid migraine. The headaches experienced by patients could be distinguished based on their trigeminal autonomic symptoms, pulsating character, severity, and pain location.
Conclusions: Distinct characteristics of CH remained unchanged in patients with comorbid migraine with the exception of an increased frequency of chronic CH. The most appropriate management of CH requires clinicians to check the history of preceding migraine, particularly in cases of chronic CH.
Calandre E, Ordonez-Carrasco J, Slim M, Rico-Villademoros F, Garcia-Leiva J J Oral Facial Pain Headache. 2025; 38(1):32-39.
PMID: 39788574 PMC: 11774279. DOI: 10.22514/jofph.2024.004.
Research hotspots and frontiers of cluster headaches: a bibliometric analysis.
Mao Q, Xu S, Wang Y, Wu D, Huang G, Li Z Front Neurol. 2024; 15:1395770.
PMID: 38725643 PMC: 11079126. DOI: 10.3389/fneur.2024.1395770.
Kashiwagi K, Katsuki M, Kawamura S, Tachikawa S, Ono A, Koh A Neurol Int. 2023; 15(1):318-324.
PMID: 36976663 PMC: 10057600. DOI: 10.3390/neurolint15010020.
Cranial Autonomic Symptoms and Neck Pain in Differential Diagnosis of Migraine.
Nunes Vicente B, Oliveira R, Martins I, Gil-Gouveia R Diagnostics (Basel). 2023; 13(4).
PMID: 36832077 PMC: 9955923. DOI: 10.3390/diagnostics13040590.
Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache.
Mo H, Kim B, Moon H, Cho S J Headache Pain. 2022; 23(1):132.
PMID: 36209047 PMC: 9547445. DOI: 10.1186/s10194-022-01505-w.